LRFN1 and neoplasm: In this study, we hypothesized that miR-187-3p may play a role in suppressing tumors, and mediates malignancy and tumor immune microenvironment (TIME) by targeting Leucine Rich Repeat and Fibronectin Type III Domain Containing 1 (LRFN1).